Jabra Enhance Select 700 vs Otofonix Groove

The Jabra Enhance Select 700 is a premium-priced OTC hearing aid available at $1,795, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This behind-the-ear device ranks #26 of 65 OTC hearing aids tested, placing it in the top 38% of the category. In our testing, the Enhance Select 700 shows notable strengths in own-voice comfort, scoring 3.7/5—a solid result that sits 1.19 points above the category average. This makes it a comfortable choice for users sensitive to the "hollow" sound of their own voice that some hearing aids produce. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during typical daily activities. Speech clarity in quiet environments is solid at 3.1/5, coming in 0.27 points above the category average. However, speech understanding in noisy settings is a weakness, scoring just 1.0/5—falling 0.48 points below the category average. Users who frequently encounter restaurants, group gatherings, or other challenging listening environments may find this limitation significant. Music streaming quality is mixed at 2.5/5, though still 0.58 points above the category average. At this price point, buyers should note that several same-priced alternatives deliver stronger overall performance, including the Lucid Tala (4.63/5) and Audicus Omni 2 (4.61/5). The Enhance Select 700 is best suited for users who prioritize own-voice comfort and feedback-free wear over speech-in-noise performance, and who value Jabra's established brand and support ecosystem.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.